Quest Diagnostics Declares Quarterly Cash Dividend
Quest Diagnostics (NYSE: DGX), a leading diagnostic information services provider, has announced a quarterly cash dividend. The company's Board of Directors has declared a dividend of $0.80 per share. The dividend will be paid on October 20, 2025, to shareholders who hold Quest Diagnostics common stock as of the record date of October 3, 2025.
Quest Diagnostics (NYSE: DGX), principale fornitore di servizi informativi diagnostici, ha annunciato un dividendo in contanti trimestrale. Il Consiglio di Amministrazione ha dichiarato un dividendo di $0,80 per azione. Il pagamento sarà effettuato il 20 ottobre 2025 agli azionisti che risultano titolari delle azioni ordinarie di Quest Diagnostics alla data record del 3 ottobre 2025.
Quest Diagnostics (NYSE: DGX), un destacado proveedor de servicios de información diagnóstica, ha anunciado un dividendo trimestral en efectivo. El Consejo de Administración ha aprobado un dividendo de $0.80 por acción. El dividendo se pagará el 20 de octubre de 2025 a los accionistas que sean propietarios de acciones ordinarias de Quest Diagnostics en la fecha registral del 3 de octubre de 2025.
Quest Diagnostics (NYSE: DGX)는 선도적인 진단 정보 서비스 제공업체로서 분기 현금 배당을 발표했습니다. 이사회는 주당 $0.80의 배당금을 선언했습니다. 배당금은 2025년 10월 20일에 지급되며, 기준일인 2025년 10월 3일 현재 Quest Diagnostics 보통주를 보유한 주주에게 지급됩니다.
Quest Diagnostics (NYSE: DGX), un fournisseur leader de services d'information diagnostique, a annoncé un dividende trimestriel en espèces. Le conseil d'administration a déclaré un dividende de 0,80 $ par action. Le dividende sera versé le 20 octobre 2025 aux actionnaires détenant des actions ordinaires de Quest Diagnostics à la date d'enregistrement du 3 octobre 2025.
Quest Diagnostics (NYSE: DGX), ein führender Anbieter diagnostischer Informationsdienste, hat eine vierteljährliche Bardividende angekündigt. Der Vorstand hat eine Dividende von $0,80 je Aktie beschlossen. Die Dividende wird am 20. Oktober 2025 an Aktionäre ausgezahlt, die am Stichtag, dem 3. Oktober 2025, Inhaber von Quest Diagnostics Stammaktien sind.
- None.
- None.
About Quest Diagnostics
Quest Diagnostics works across the healthcare ecosystem to create a healthier world, one life at a time. We provide diagnostic insights from the results of our laboratory testing to empower people, physicians and organizations to take action to improve health outcomes. Derived from one of the world's largest databases of de-identifiable clinical lab results, Quest's diagnostic insights reveal new avenues to identify and treat disease, inspire healthy behaviors and improve healthcare management. Quest annually serves one in three adult Americans and half the physicians and hospitals in the
View original content to download multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-declares-quarterly-cash-dividend-302529498.html
SOURCE Quest Diagnostics
FAQ
What is Quest Diagnostics' (DGX) dividend amount for Q4 2025?
When is Quest Diagnostics' (DGX) next dividend payment date?
What is the record date for Quest Diagnostics' (DGX) Q4 2025 dividend?
How often does Quest Diagnostics (DGX) pay dividends?
